Optimal Surgery Timing After Chemo in Esophageal Cancer? Optimal Surgery Timing After Chemo in Esophageal Cancer?
New data show that survival outcomes were best when surgery came 6 –8 weeks after neoadjuvant chemotherapy. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
FAPI-PET visualizes myocardial fibrosis on molecular level
PET imaging with a fibroblast activation protein inhibitor (FAPI) radiotrace...Read more on AuntMinnie.comRelated Reading:
FAPI-PET cuts tracer injection wait times by more than two-thirds
FAPI-PET predicts outcomes in patients with esophageal cancer
SNMMI Image of the Year predicts poor outcomes after heart attack
FAPI-PET shows promise detecting biliary tract cancer
FAPI-PET may improve diagnosis of gastric cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 22, 2022 Category: Radiology Source Type: news
Eating hot soup could increase the risk of oesophageal cancer - how to protect yourself
"Letting hot drinks or hot food such as soup cool down before eating makes good sense," said Dr Deborah Lee. (Source: Daily Express - Health)
Source: Daily Express - Health - December 16, 2022 Category: Consumer Health News Source Type: news
Post-op Chemo Has Limited Benefit in Some Esophageal Cancers Post-op Chemo Has Limited Benefit in Some Esophageal Cancers
Patients with stage IIA and IIB esophageal squamous cell carcinoma with lymphovascular invasion but negative lymph nodes do not benefit. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 16, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
These Factors Increase the Risk of Kidney Cancer
Kidney cancer is one of the 10 most-diagnosed cancers in the United States. Like many of the other cancers on that list—including colon and rectal cancer—kidney cancer is more common now than it used to be. But unlike some others, the underlying causes of kidney cancer are often hard to discern.
For example, a significant proportion of breast cancers stem from inherited genetic mutations. But that’s not the case for kidney cancer. Just 3% to 5% of these cancers are caused by hereditary factors. “There are certain genetic conditions associated with increased risk, but the vast majority of kidney canc...
Source: TIME: Health - December 13, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Dysphagia is the 'first' symptom of oesophageal cancer - 'See your GP without delay'
There are approximately 9,000 new cases of oesophageal cancer diagnosed every year in the UK. (Source: Daily Express - Health)
Source: Daily Express - Health - December 12, 2022 Category: Consumer Health News Source Type: news
Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
New cancer center coming to CU Anschutz
The new center's creation in Aurora coincides with a rise in esophageal cancer across the nation. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 7, 2022 Category: American Health Authors: Analisa Romano Source Type: news
‘Fit’ teen suffers ‘horrific’ chemo effects as family try to raise money for cancer jab
The teenager has a form of oesophageal carcinoma, which is extremely rare for children and adolescents to get. (Source: Daily Express - Health)
Source: Daily Express - Health - November 19, 2022 Category: Consumer Health News Source Type: news
FAPI-PET cuts tracer injection wait times by more than two-thirds
Fibroblast activation protein inhibitor (FAPI)-PET diagnostic cancer imagin...Read more on AuntMinnie.comRelated Reading:
FAPI-PET predicts outcomes in patients with esophageal cancer
First patient imaged in Sofie's FAPI-PET trial
SNMMI Image of the Year predicts poor outcomes after heart attack
FAPI-PET shows promise detecting biliary tract cancer
Ga-68 radiotracer outperforms F-18 FDG in lung cancer staging (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2022 Category: Radiology Source Type: news
How Bladder Cancer Differs in Women and Younger Adults
Bladder cancer is one of the most commonly diagnosed forms of cancer in the U.S. About 1 in 40 Americans born today will develop this cancer at some point in their lifetime, and a majority of these people will be males over the age of 60. Bladder cancer is the fourth most common cancer in American men, representing more than 6% of all cancers in males.
But while men are three to four times more likely than women to develop bladder cancer, the disease tends to be deadlier in females. Women are also more likely to be diagnosed with larger bladder tumors. Why? These are questions that medical researchers have puzzled over for...
Source: TIME: Health - November 15, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Highlights in Esophageal Research From ACG 2022 Highlights in Esophageal Research From ACG 2022
Highlights in esophageal diseases from ACG 2022 include data on use of dupilumab in eosinophilic esophagitis, achalasia as risk for esophageal cancer, and vonoprazan in nonerosive reflux disease.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2022 Category: Consumer Health News Tags: None ReCAP Source Type: news
Mayo Clinic Q & amp;A podcast: Barrett's esophagus requires monitoring and treatment to decrease esophageal cancer risk
Barrett's esophagus is a condition in which the lining esophagus becomes damaged by acid reflux, which causes the lining to thicken and become red. Over time, the valve between the esophagus and the stomach may begin to fail, leading to acid and chemical damage of the esophagus, a condition called gastroesophageal reflux disease, or GERD. In some people, GERD may trigger a change in the cells that line the lower esophagus, causing Barrett's esophagus. "The stomach is well… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 8, 2022 Category: Databases & Libraries Source Type: news
My Risk Revealed: A Confirmed BRCA2 Mutation
(MedPage Today) -- Cancer is a part of my family story. My grandmother on my father's side died of pancreatic adenocarcinoma in her early 70s, when I was a young teenager. My grandfather and uncle died of esophageal cancer in their early 50s. So... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 30, 2022 Category: Hematology Source Type: news
Adults With Chronic Acid Reflux Rarely Get Recommended Test
People with GERD are at risk for Barrett's and cancer of the esophagus. Yet in a survey of 472 adults with GERD, only 13% had ever been advised by their doctor to undergo screening endoscopy and even fewer actually had the imaging test. (Source: WebMD Health)
Source: WebMD Health - October 27, 2022 Category: Consumer Health News Source Type: news
